Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Current assets    
Cash and cash equivalents $ 393,032 $ 341,382
Restricted cash 52,389 12,017
Accounts receivable, net of allowance for doubtful accounts of $5,956 (2011 — $2,725) 676,111 240,425
Rebates receivable 248,215 33,834
Other current assets 140,376 35,605
Total current assets 1,510,123 663,263
Property and equipment, net of accumulated depreciation of $56,759 (2011 — $43,304) 80,090 21,658
Goodwill 4,471,582 291,045
Other intangible assets, net of accumulated amortization of $118,782 (2011 — $48,072) 1,258,397 69,777
Other long-term assets 53,016 4,564
Total assets 7,373,208 1,050,307
Current liabilities    
Accounts payable 633,675 219,380
Accrued expenses and other current liabilities 268,401 66,729
Pharmacy benefit management rebates payable 248,536 59,235
Current portion - long-term debt 27,500 0
Total current liabilities 1,178,112 345,344
Deferred income taxes 343,332 18,361
Long term debt 1,244,425 0
Other long-term liabilities 54,462 15,564
Total liabilities 2,820,331 379,269
Commitments and contingencies (Note 12)      
Shareholders’ equity    
Common shares: no par value, unlimited shares authorized; 205,137,882 shares issued and outstanding at September 30, 2012 (December 31, 2011 — 124,767,322 shares) 4,177,804 394,769
Additional paid-in capital 67,795 37,936
Retained earnings 312,462 238,333
Accumulated other comprehensive income (2,504) 0
Total shareholders' equity 4,555,557 671,038
Non-controlling interest (2,680) 0
Total equity 4,552,877 671,038
Total liabilities and equity $ 7,373,208 $ 1,050,307